These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Adjuvant Therapy Use and Survival in Stage II Endometrial Cancer. Lester-Coll NH, Young MR, Park HS, Ratner ES, Litkouhi B, Damast S. Int J Gynecol Cancer; 2017 Nov; 27(9):1904-1911. PubMed ID: 28763364 [Abstract] [Full Text] [Related]
25. Adjuvant chemotherapy for advanced endometrial cancer. Galaal K, Al Moundhri M, Bryant A, Lopes AD, Lawrie TA. Cochrane Database Syst Rev; 2014 May 15; 2014(5):CD010681. PubMed ID: 24832785 [Abstract] [Full Text] [Related]
26. Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial cancer. AlHilli MM, Mariani A, Bakkum-Gamez JN, Dowdy SC, Weaver AL, Peethambaram PP, Keeney GL, Cliby WA, Podratz KC. Gynecol Oncol; 2014 Jun 15; 133(3):485-93. PubMed ID: 24690476 [Abstract] [Full Text] [Related]
28. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma. Hiura M, Nogawa T, Matsumoto T, Yokoyama T, Shiroyama Y, Wroblewski J. Int J Gynecol Cancer; 2010 Aug 15; 20(6):1000-5. PubMed ID: 20683408 [Abstract] [Full Text] [Related]
36. Adjuvant treatment and outcomes for patients with stage IIIA grade 1 endometrioid endometrial cancer. Montes de Oca MK, Albright BB, Secord AA, Havrilesky LJ, Moss HA. Int J Gynecol Cancer; 2021 Dec 15; 31(12):1549-1556. PubMed ID: 34725205 [Abstract] [Full Text] [Related]